Michael P Brown

18PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursArtificial life and complex adaptive systemsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 24, 2026
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Nov 04, 2025
Automating cancer registries: Pearls and pitfalls.

Shrirajh Satheakeerthy, Mark Beecher, Andrew Ec Booth

|May 16, 2024
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.

Tessa Gargett, Nga T H Truong, Bryan Gardam

|Sep 21, 2023
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.

Daphne Day, John J Park, Jermaine Coward

|May 03, 2023
Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy.

Jake R Thompson, Julia Lai-Kwon, Rachael L Morton

Pageof 3

Frequent Collaborators

4 joint publications

Nicole L Wittwer

4 joint publications

Tessa Gargett

3 joint publications

Lisa M Ebert

3 joint publications

Vasilios Liapis